Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
This Month's Bonus News 3 Blue-Chip Stocks Built for a Rotating MarketWritten by Chris Markoch. Originally Published: 3/8/2026. 
Quick Look - Sector rotation in 2026 is favoring defensive, value-oriented areas such as utilities, healthcare, and consumer staples over mega-cap technology.
- Duke Energy and Gilead Sciences combine defensive characteristics with identifiable growth catalysts and reliable dividends.
- Hershey has rallied sharply with consumer staples, but its valuation now looks stretched relative to its earnings profile.
Sector rotation occurs when investors move money out of market sectors that look overbought and into ones that seem undervalued. In 2026, that has meant shifting away from mega-cap technology names and toward value-oriented, defensive sectors such as energy and consumer staples. The key word is overvalued. Big tech has been running hot for more than two years, driven largely by the emergence of artificial intelligence (AI). Despite concerns about a repeat of the dot-com era, investors largely ignored the lofty valuations of many of these names. Elf Labs has secured historic rights (500+ assets) to iconic characters like Cinderella and Snow White. They're bringing them to life through multi-patented immersive technology across entertainment, gaming, and consumer products – a market estimated at over $2 trillion.
Valuation has grown 17X (a 1,600% increase) in under 24 months, and the company just reserved its NASDAQ ticker: $ELFS.
For a limited time, everyday investors can still participate at $2.25/share (plus up to 35% bonus shares) while the company remains privately held. Invest Now But valuation often doesn't matter until it does. As the economy shows signs of heating up, investors are seeking value elsewhere — including in blue-chip, defensive names such as the stocks discussed below. Utilities Provide Stability in a Rotating Market Duke Energy (NYSE: DUK) is a logical beneficiary of sector rotation. Duke is a well-known utility provider in the Southeast and Midwest United States. Utility stocks are among the most defensive and are typically classified as value and income plays. Duke offers an attractive, dependable dividend that yields about 3.2%, and the company has increased the payout for 20 consecutive years. The changing U.S. energy landscape also creates opportunities for future growth at DUK. The company takes an "all of the above" approach to power generation, including nuclear, hydroelectric and natural gas. Natural gas has helped fuel the stock's strong bounce in 2026, but Duke's steady residential utility revenue, along with projected growth areas such as data centers, are what make DUK a target in the current rotation. DUK is up nearly 12% in 2026, putting it within about 5% of its consensus price target of $136.87, which would push the shares above their 52-week high. At roughly 20.5x earnings, the stock trades at a slight premium to its historical average. Since the company reported earnings in February, analysts have been raising price targets as they anticipate strong year-over-year revenue growth in the second half of the year — a setup that could produce a bullish re-rating. Biotech Strength Gives Gilead Defensive Growth Some strategists expect biotechnology to benefit from this rotation. Gilead Sciences (NASDAQ: GILD) offers defensive growth within the healthcare sector, which has lagged the broader market. Gilead is a leading provider of HIV therapies, with key drugs that have patent protection into the 2030s. Investors are also encouraged by the company's pipeline of more than 50 candidates. Beyond HIV, Gilead expects to launch anito-cel, a CAR-T therapy for multiple myeloma, in 2026 and could see a label expansion for its breast cancer drug Trodelvy. GILD is up nearly 18% in 2026 and reached a 52-week high earlier in the year. It has pulled back slightly from that peak, likely due to some profit-taking after the sharp run-up, which could create a buy-the-dip opportunity. Analysts have a consensus price target of $156.72, implying upside of just over 8%. Since February's earnings, many analysts have raised targets, with the most bullish call around $170. Gilead also pays a steady dividend, yielding about 2.28%, and has raised its payout for 10 consecutive years. Consumer Staples Rally Lifts Hershey Stock The Hershey Company (NYSE: HSY) is a strong beneficiary of the rotation into consumer staples in 2026. HSY is up nearly 25% this year and has broken out of the bearish trend it had been in since 2023. Earlier, Hershey contended with higher cocoa costs that extended into 2025 — a headwind that will continue to affect earnings in 2026. Still, the market looks forward, and analysts are forecasting stronger revenue and earnings later this year. HSY is trading above its consensus price target of $222.21. Since the company's February earnings, analysts have been raising targets, with the most bullish call from Goldman Sachs at $267. In that report, Hershey also raised its dividend by 5.9%, marking 15 consecutive years of increases for a company that yields about 2.5% and pays an annual $5.81 per share. After the recent run-up, HSY trades at north of 50x earnings, which likely prompted heavy institutional selling in the last quarter. That valuation could, however, offer patient investors another opportunity to buy into this well-known name.
| 
